For sales

📢Highlights from the Week of 5 November – 10 November 2025 in the world of pharma and healthcare! 🗞️👀

Highlights from the Week of 5 November - 10 November 2025 ( FDA, Approval ) FDA approves OMVOH (mirikizumab‐mrkz) for once-monthly, single-injection maintenance in adults with ulcerative colitis ( Health Canada, Approval ) Health Canada authorizes LEQEMBI (lecanemab) for treating early Alzheimer’s disease in adults ( FDA, Interchangeable ) CONEXXENCE and BOMYNTRA from Fresenius Kabi now FDA-designated interchangeable biosimilars to denosumab ( FDA, Interchangeable ) Celltrion’s denosumab biosimilars, STOBOCLO and OSENVELT, receive FDA interchangeability designation Pg 1/2 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.